PTCT
PTC Therapeutics Inc
Price:  
49.99 
USD
Volume:  
826,543.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

PTCT WACC - Weighted Average Cost of Capital

The WACC of PTC Therapeutics Inc (PTCT) is 7.8%.

The Cost of Equity of PTC Therapeutics Inc (PTCT) is 9.35%.
The Cost of Debt of PTC Therapeutics Inc (PTCT) is 5.50%.

Range Selected
Cost of equity 7.90% - 10.80% 9.35%
Tax rate 4.90% - 6.40% 5.65%
Cost of debt 4.00% - 7.00% 5.50%
WACC 6.4% - 9.2% 7.8%
WACC

PTCT WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.87 1.05
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.90% 10.80%
Tax rate 4.90% 6.40%
Debt/Equity ratio 0.57 0.57
Cost of debt 4.00% 7.00%
After-tax WACC 6.4% 9.2%
Selected WACC 7.8%